Hematology/ Oncology and Stem Cell Therapy

Aims & Scope

Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology.

The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports.

It also offers a special section for clinically relevant images that provide an important educational value.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.554

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	31

Journal Rank

Year	Value
2024	10507

Journal Citation Indicator

Year	Value
2024	258

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Natural killer cells

  Citation: 219

  Authors: Arundhati, Chandra

• Long-term complications after hematopoietic cell transplantation

  Citation: 160

  Authors: Navneet S.

• Cancer care in Jordan

  Citation: 121

  Authors: Hikmat, Fadwa, Asem

• Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation

  Citation: 92

  Authors: Jose F., Krishna V.

• Acinic cell carcinoma of the salivary glands

  Citation: 85

  Authors: Nabil, Amani, Suhail, Bassam Sulaiman

• The Risk and Prognosis of COVID-19 Infection in Cancer Patients

  Citation: 77

  Authors: Ghada M., Shahrukh, Jan, Mohamed A., Rehab M., Rafael, Sherif, Alfadel, Simone, Nashwa Abd, Reem, Usama, Navneet S., Yasser, Roy F., Mahmoud, Riad

• The immunoinhibitory B7-H1 molecule as a potential target in cancer

  Citation: 76

  Authors: Said, Sehar

• Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000–2010

  Citation: 75

  Authors: Fazal, Samra, Asif, Shouki, Tusneem, Naeem

• Viral-associated thrombotic microangiopathies

  Citation: 74

  Authors: Rodrigo Lopes

• Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation

  Citation: 71

  Authors: Navneet S., J. Douglas, Stephanie J., Mahmoud, Yoshiko, Carmem, Linda J., Naeem, Stella, Shinichiro, Adriana, Gerard, Jeff, Maria Teresa, John R, Andre

---